Preclinical evaluation of 2-amino-2-[11C]methyl-butanoic acid as a potential tumor-imaging agent in a mouse model. Issue 11 (November 2015)
- Record Type:
- Journal Article
- Title:
- Preclinical evaluation of 2-amino-2-[11C]methyl-butanoic acid as a potential tumor-imaging agent in a mouse model. Issue 11 (November 2015)
- Main Title:
- Preclinical evaluation of 2-amino-2-[11C]methyl-butanoic acid as a potential tumor-imaging agent in a mouse model
- Authors:
- Suzuki, Chie
Tsuji, Atsushi B.
Kato, Koichi
Sudo, Hitomi
Zhang, Ming-Rong
Saga, Tsuneo - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objective</title> <p> <sup>14</sup>C-labeled 2-amino-2-methyl-butanoic acid (Iva) was previously reported to provide high tumor uptake; however, the pharmacokinetic properties of <sup>11</sup>C-labeled Iva have not been characterized. In the present study, we evaluated the potential of [<sup>11</sup>C]Iva as a PET probe for tumor imaging.</p> </sec> <sec> <title>Methods</title> <p>[<sup>11</sup>C]Iva was incubated in mouse serum for 60 min at 37°C and then analyzed by high-performance liquid chromatography and thin-layer chromatography. In-vitro cellular uptake of [<sup>11</sup>C]Iva was determined in PBS and sodium-free buffer at 37°C using SY human small-cell lung cancer cells. The effects of inhibitors of amino acid transporters on [<sup>11</sup>C]Iva uptake were also determined in PBS. In-vivo distribution and dynamic PET studies were conducted in SY tumor-bearing mice.</p> </sec> <sec> <title>Results</title> <p>[<sup>11</sup>C]Iva was stable in mouse serum <italic>in vitro</italic> for 60 min. The cellular uptake of [<sup>11</sup>C]Iva was linearly increased for 20 min in both PBS and sodium-free buffer and almost completely inhibited by an inhibitor of system L amino acid transporters and another of LAT1, a transporter of system L. In-vivo distribution and dynamic PET studies showed that [<sup>11</sup>C]Iva was highly accumulated in tumor, but not in normal tissues, except for the pancreas<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objective</title> <p> <sup>14</sup>C-labeled 2-amino-2-methyl-butanoic acid (Iva) was previously reported to provide high tumor uptake; however, the pharmacokinetic properties of <sup>11</sup>C-labeled Iva have not been characterized. In the present study, we evaluated the potential of [<sup>11</sup>C]Iva as a PET probe for tumor imaging.</p> </sec> <sec> <title>Methods</title> <p>[<sup>11</sup>C]Iva was incubated in mouse serum for 60 min at 37°C and then analyzed by high-performance liquid chromatography and thin-layer chromatography. In-vitro cellular uptake of [<sup>11</sup>C]Iva was determined in PBS and sodium-free buffer at 37°C using SY human small-cell lung cancer cells. The effects of inhibitors of amino acid transporters on [<sup>11</sup>C]Iva uptake were also determined in PBS. In-vivo distribution and dynamic PET studies were conducted in SY tumor-bearing mice.</p> </sec> <sec> <title>Results</title> <p>[<sup>11</sup>C]Iva was stable in mouse serum <italic>in vitro</italic> for 60 min. The cellular uptake of [<sup>11</sup>C]Iva was linearly increased for 20 min in both PBS and sodium-free buffer and almost completely inhibited by an inhibitor of system L amino acid transporters and another of LAT1, a transporter of system L. In-vivo distribution and dynamic PET studies showed that [<sup>11</sup>C]Iva was highly accumulated in tumor, but not in normal tissues, except for the pancreas and kidneys. The [<sup>11</sup>C]Iva uptake ratio of tumor to several normal tissues, such as the lung, muscle, and brain, was high.</p> </sec> <sec> <title>Conclusion</title> <p>[<sup>11</sup>C]Iva was stable in mouse serum and transported through system L amino acid transporters including LAT1, which is highly expressed in several tumors. [<sup>11</sup>C]Iva is a promising PET probe for noninvasive tumor imaging.</p> </sec> </abstract> … (more)
- Is Part Of:
- Nuclear medicine communications. Volume 36:Issue 11(2015:Nov.)
- Journal:
- Nuclear medicine communications
- Issue:
- Volume 36:Issue 11(2015:Nov.)
- Issue Display:
- Volume 36, Issue 11 (2015)
- Year:
- 2015
- Volume:
- 36
- Issue:
- 11
- Issue Sort Value:
- 2015-0036-0011-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-11
- Subjects:
- Nuclear medicine -- Periodicals
616.07575 - Journal URLs:
- http://journals.lww.com/nuclearmedicinecomm/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
http://www.lww.com/Product/0143-3636 ↗ - DOI:
- 10.1097/MNM.0000000000000364 ↗
- Languages:
- English
- ISSNs:
- 0143-3636
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6180.923000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2969.xml